Fleming-Dutra Katherine E, Demirjian Alicia, Bartoces Monina, Roberts Rebecca M, Taylor Thomas H, Hicks Lauri A
From the *Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion, National Center for Emerging and Infectious Diseases, Centers for Disease Control and Prevention, †Epidemic Intelligence Service, Centers for Disease Control and Prevention, ‡Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, and §Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pediatr Infect Dis J. 2018 Jan;37(1):52-58. doi: 10.1097/INF.0000000000001708.
Using antibiotics appropriately is critical to slow spread of antibiotic resistance, a major public health problem. Children, especially young children, receive more antibiotics than other age groups. Our objective was to describe antibiotic use in children in the United States and use of azithromycin, which is recommended infrequently for pediatric conditions.
We used QuintilesIMS Xponent 2013 data to calculate the number and rate of oral antibiotic prescriptions for children by age (0-2, 3-9 and 10-19 years) and agent. We used log-binomial regression to calculate adjusted prevalence ratios and 95% confidence intervals to determine if specialty and patient age were associated with azithromycin selection when an antibiotic was prescribed.
In 2013, 66.8 million antibiotics were prescribed to US children ≤19 years of age (813 antibiotic prescriptions per 1000 children). Amoxicillin and azithromycin were the 2 most commonly prescribed agents (23.1 million courses, 35% of all antibiotics; 12.2 million, 18%, respectively). Most antibiotics for children were prescribed by pediatricians (39%) and family practitioners (15%). Family practitioners were more likely to select azithromycin when an antibiotic was prescribed in all age groups than pediatricians (for children 0-2 years of age: prevalence ratio: 1.79, 95% confidence interval: 1.78-1.80; 3-9 years: 1.40, 1.40-1.40 and 10-19 years: 1.18, 1.18-1.18).
Despite infrequent pediatric recommendations, variations in pediatric azithromycin use may suggest inappropriate antibiotic selection. Public health interventions focused on improving antibiotic selection in children as well as reducing antibiotic overuse are needed.
合理使用抗生素对于减缓抗生素耐药性的传播至关重要,而抗生素耐药性是一个重大的公共卫生问题。儿童,尤其是幼儿,比其他年龄组接受更多的抗生素治疗。我们的目的是描述美国儿童的抗生素使用情况以及阿奇霉素的使用情况,阿奇霉素在儿科疾病中的推荐使用频率较低。
我们使用昆泰IMS Xponent 2013数据,按年龄(0 - 2岁、3 - 9岁和10 - 19岁)和药物计算儿童口服抗生素处方的数量和比率。我们使用对数二项回归来计算调整后的患病率比值和95%置信区间,以确定在开具抗生素处方时,专科类型和患者年龄是否与阿奇霉素的选择有关。
2013年,19岁及以下的美国儿童共开具了6680万份抗生素处方(每1000名儿童有813份抗生素处方)。阿莫西林和阿奇霉素是最常用的两种药物(分别为2310万疗程,占所有抗生素的35%;1220万疗程,占18%)。大多数儿童抗生素处方由儿科医生(39%)和家庭医生(15%)开具。在所有年龄组中,开具抗生素处方时,家庭医生比儿科医生更有可能选择阿奇霉素(0 - 2岁儿童:患病率比值:1.79,95%置信区间:1.78 - 1.80;3 - 9岁:1.40,1.40 - 1.40;10 - 19岁:1.18, 1.18 - 1.18)。
尽管儿科推荐使用阿奇霉素的频率较低,但儿科阿奇霉素使用的差异可能表明抗生素选择不当。需要开展公共卫生干预措施,重点是改善儿童抗生素的选择以及减少抗生素的过度使用。